The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
Welcome to IDEA Collider. In this episode, host Dr. Alex Gray, Chief Medical and Innovation Officer at IDEA Pharma, is joined by colleague Jacqueline Poot, President of Strategic Consulting and Analytics, to discuss the intricacies of pharmaceutical portfolio strategy. They tackle the growing view that the pharmaceutical industry doesn't just have a science problem; it has an execution problem. Alex breaks down how human biases, such as confirmation bias and champion bias, can derail clinical development and lead to poor portfolio choices. They emphasize that stopping a failing project early is just as critical to an organization's overall success as advancing a good one.
Subscribe to our newsletter for more insights.
Further reading
-
The Execution Problem: Alex Gray and Jacqueline Poot on Pharma Decision Intelligence.
-
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution
-
Innovation
Eli Lilly top 2026 Global Pharmaceutical Innovation & Invention Index
Eli Lilly top 2026 Global Pharmaceutical Innovation & Invention Index


